Vicebio

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$100M

Vicebio Ltd is a biopharmaceutical company developing next-generation multivalent respiratory virus vaccines using proprietary Molecular Clamp technology.

Total Funding

$100M

Headquarters

London, United Kingdom

Founded

N/A

Website

vicebio.com

Focus Areas

biopharmaceutical

vaccines

Molecular Clamp technology

respiratory viruses

Phase I clinical study

multivalent pipeline

Investors